Exane Derivatives’s Abercrombie & Fitch ANF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5
Closed -$80 657
2019
Q2
$80 Buy
+5
New +$116 ﹤0.01% 644
2019
Q1
Sell
-29,607
Closed -$593K 656
2018
Q4
$593K Sell
29,607
-4,345
-13% -$81.4K 0.11% 163
2018
Q3
$723K Buy
33,952
+20,300
+149% +$492K 0.14% 137
2018
Q2
$346K Sell
13,652
-3,947
-22% -$103K 0.06% 201
2018
Q1
$417K Sell
17,599
-6,753
-28% -$143K 0.08% 171
2017
Q4
$424K Sell
24,352
-249,438
-91% -$3.79M 0.07% 187
2017
Q3
$3.95M Buy
273,790
+28,596
+12% +$327K 0.74% 24
2017
Q2
$3.05M Buy
245,194
+792
+0.3% +$9.76K 0.65% 31
2017
Q1
$2.92M Buy
244,402
+148,702
+155% +$1.77M 0.66% 40
2016
Q4
$1.15M Sell
95,700
-100,008
-51% -$1.49M 0.23% 86
2016
Q3
$3.11M Buy
+195,708
New +$3.78M 0.47% 53
2016
Q2
Sell
-869
Closed -$20.7K 556
2016
Q1
$27.4K Buy
+869
New +$24.4K ﹤0.01% 362
2015
Q3
Sell
-77,851
Closed -$1.58M 536
2015
Q2
$1.67M Sell
77,851
-42,797
-35% -$942K 0.18% 70
2015
Q1
$2.66M Buy
120,648
+88,849
+279% +$2.19M 0.29% 56
2014
Q4
$911K Buy
+31,799
New +$976K 0.13% 99

Other funds holding ANF

Exane Derivatives's ANF Position: Q3 2019 in Review

Exane Derivatives sold out of Abercrombie & Fitch (ANF) in Q3 2019, closing a stake of 5 shares — an estimated $80 sold.

Exane Derivatives first reported a position in ANF in Q4 2014 and held it in 15 quarters. The position peaked at $3.95M in Q3 2017. 198 funds tracked by Wall St. Rank hold ANF as of Q3 2019.

  • Exane Derivatives reported no remaining Abercrombie & Fitch position as of Q3 2019 after selling out during the quarter.
  • Exane Derivatives sold 5 Abercrombie & Fitch shares in Q3 2019, an estimated $80.
  • Exane Derivatives first reported a position in Abercrombie & Fitch in Q4 2014 and held it in 15 quarters.
  • Exane Derivatives's Abercrombie & Fitch position peaked at $3.95M in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.